Serum bile acid patterns are associated with the presence of NAFLD in twins, and dose-dependent changes with increase in fibrosis stage in patients with biopsy-proven NAFLD

被引:131
作者
Caussy, Cyrielle [1 ,2 ]
Hsu, Cynthia [1 ]
Singh, Seema [1 ]
Bassirian, Shirin [1 ]
Kolar, James [1 ]
Faulkner, Claire [1 ]
Sinha, Nikhil [1 ]
Bettencourt, Ricki [1 ,3 ]
Gara, Naveen [5 ]
Valasek, Mark A. [4 ]
Schnabl, Bernd [5 ]
Richards, Lisa [1 ]
Brenner, David A. [1 ,5 ]
Hofmann, Alan F. [5 ]
Loomba, Rohit [1 ,3 ,5 ]
机构
[1] Univ Calif San Diego, Dept Med, NAFLD Res Ctr, La Jolla, CA 92093 USA
[2] Univ Lyon 1, Hosp Civils Lyon, Lyon, France
[3] Univ Calif San Diego, Dept Family Med & Publ Hlth, Div Epidemiol, La Jolla, CA 92093 USA
[4] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA
[5] Dept Med, Div Gastroenterol, La Jolla, CA 92093 USA
关键词
NONALCOHOLIC FATTY LIVER; HEPATIC STEATOSIS; NUCLEAR RECEPTOR; GUT MICROBIOTA; DISEASE; STEATOHEPATITIS; CIRRHOSIS; IDENTIFICATION; INFLAMMATION; PROGRESSION;
D O I
10.1111/apt.15035
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Background The fasting-state serum bile acid profile in nonalcoholic fatty liver disease (NAFLD) has been reported to differ when nonalcoholic steatohepatitis is compared to nonalcoholic fatty liver. However, there are few data comparing changes in NAFLD vs non-NAFLD, or whether the bile acid profile differs according to the degree of fibrosis. Aim To examine the serum bile acid profile across the entire spectrum of NAFLD. Methods We performed a cross-sectional analysis of two complementary cohorts: a Twin and Family cohort of 156 participants, and a biopsy-proven-NAFLD cohort of 156 participants with fasting bile acid profiling using liquid chromatography/mass spectrometry. Results In the Twin and Family cohort (mean age 46.3 years and body mass index (BMI) 26.6 kg/m(2)), 36 (23%) participants had NAFLD (magnetic resonance imaging proton density fat fraction >= 5%). Higher chenodeoxycholyl conjugates (9.0% vs 6.5%, P = 0.019) and lower glycohyocholate (1.2% vs 3.6%, P < 0.001) were observed in NAFLD compared to non-NAFLD-controls. In the biopsy-proven-NAFLD cohort (mean age 49.8 years, BMI 32.0 kg/m(2)), no differences in total bile acid were seen between nonalcoholic fatty liver vs nonalcoholic steatohepatitis. The total unconjugated bile acid significantly decreased across nonalcoholic steatohepatitis categories (P = 0.044). The distribution of stage of fibrosis was F0: 42.3%, F1: 32.7%, F2: 10.3%, F3: 8.3% and F4: 6.4%. The total serum bile acid increased with increase in fibrosis stage (P < 0.001). The primary conjugated bile acid proportion increased (P < 0.001) whereas unconjugated bile acid (P = 0.006), unconjugated cholyl (P < 0.001) and chenodeoxycholyl conjugates (P < 0.002) significantly decreased with increase in liver fibrosis stage. Conclusions Fasting-state serum bile acid profile alterations are seen across the entire spectrum of NAFLD. The total serum bile acids did not differ significantly between NAFLD vs non-NAFLD and nonalcoholic fatty liver vs nonalcoholic steatohepatitis, but were significantly perturbed progressively as liver fibrosis increases.
引用
收藏
页码:183 / 193
页数:11
相关论文
共 53 条
[1]
Bile Acids Induce Inflammatory Genes in Hepatocytes A Novel Mechanism of Inflammation during Obstructive Cholestasis [J].
Allen, Katryn ;
Jaeschke, Hartmut ;
Copple, Bryan L. .
AMERICAN JOURNAL OF PATHOLOGY, 2011, 178 (01) :175-186
[2]
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease [J].
Angulo, Paul ;
Kleiner, David E. ;
Dam-Larsen, Sanne ;
Adams, Leon A. ;
Bjornsson, Einar S. ;
Charatcharoenwitthaya, Phunchai ;
Mills, Peter R. ;
Keach, Jill C. ;
Lafferty, Heather D. ;
Stahler, Alisha ;
Haflidadottir, Svanhildur ;
Bendtsen, Flemming .
GASTROENTEROLOGY, 2015, 149 (02) :389-+
[3]
Bile Acids and Nonalcoholic Fatty Liver Disease: Molecular Insights and Therapeutic Perspectives [J].
Arab, Juan P. ;
Karpen, Saul J. ;
Dawson, Paul A. ;
Arrese, Marco ;
Trauner, Michael .
HEPATOLOGY, 2017, 65 (01) :350-362
[4]
Bile acid levels are increased in the liver of patients with steatohepatitis [J].
Aranha, Marcia M. ;
Cortez-Pinto, Helena ;
Costa, Adilia ;
da Silva, Isabel B. Moreira ;
Camilo, Maria E. ;
de Moura, Miguel Carneiro ;
Rodrigues, Cecilia M. P. .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2008, 20 (06) :519-525
[5]
Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis [J].
Bechmann, Lars P. ;
Kocabayoglu, Peri ;
Sowa, Jan-Peter ;
Sydor, Svenja ;
Best, Jan ;
Schlattjan, Martin ;
Beilfuss, Anja ;
Schmitt, Johannes ;
Hannivoort, Rebekka A. ;
Kilicarslan, Alpaslan ;
Rust, Christian ;
Berr, Frieder ;
Tschopp, Oliver ;
Gerken, Guido ;
Friedman, Scott L. ;
Geier, Andreas ;
Canbay, Ali .
HEPATOLOGY, 2013, 57 (04) :1394-1406
[6]
Changes in the Intestinal Microbiome and Alcoholic and Nonalcoholic Liver Diseases: Causes or Effects? [J].
Betrapally, Naga S. ;
Gillevet, Patrick M. ;
Bajaj, Jasmohan S. .
GASTROENTEROLOGY, 2016, 150 (08) :1745-+
[7]
The Severity of Nonalcoholic Fatty Liver Disease Is Associated With Gut Dysbiosis and Shift in the Metabolic Function of the Gut Microbiota [J].
Boursier, Jerome ;
Mueller, Olaf ;
Barret, Matthieu ;
Machado, Mariana ;
Fizanne, Lionel ;
Araujo-Perez, Felix ;
Guy, Cynthia D. ;
Seed, Patrick C. ;
Rawls, John F. ;
David, Lawrence A. ;
Hunault, Gilles ;
Oberti, Frederic ;
Cales, Paul ;
Diehl, Anna Mae .
HEPATOLOGY, 2016, 63 (03) :764-775
[8]
Link between gut-microbiome derived metabolite and shared gene-effects with hepatic steatosis and fibrosis in NAFLD [J].
Caussy, Cyrielle ;
Hsu, Cynthia ;
Lo, Min-Tzu ;
Liu, Amy ;
Bettencourt, Ricki ;
Ajmera, Veeral H. ;
Bassirian, Shirin ;
Hooker, Jonathan ;
Sy, Ethan ;
Richards, Lisa ;
Schork, Nicholas ;
Schnabl, Bernd ;
Brenner, David A. ;
Sirlin, Claude B. ;
Chen, Chi-Hua ;
Loomba, Rohit .
HEPATOLOGY, 2018, 68 (03) :918-932
[9]
Caussy C, 2017, HEPATOLOGY, V66, p344A
[10]
Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis [J].
Caussy, Cyrielle ;
Soni, Meera ;
Cui, Jeffrey ;
Bettencourt, Ricki ;
Schork, Nicholas ;
Chen, Chi-Hua ;
Al Ikhwan, Mahdi ;
Bassirian, Shirin ;
Cepin, Sandra ;
Gonzalez, Monica P. ;
Mendler, Michel ;
Kono, Yuko ;
Vodkin, Irine ;
Mekeel, Kristin ;
Haldorson, Jeffrey ;
Hemming, Alan ;
Andrews, Barbara ;
Salotti, Joanie ;
Richards, Lisa ;
Brenner, David A. ;
Sirlin, Claude B. ;
Loomba, Rohit .
JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (07) :2697-2704